Neuromodin

Neuromodin sells nootropic supplements, neurostimulation devices, and at-home blood-based biomarker test kits. Single-month supplement stacks run USD 89–129 (mid-range), while the tDCS headset and bundled lab panels sit at USD 299–499 (premium). Everything is sold direct-to-consumer through neuromodin.com; no retail presence is listed. The brand positions itself as a “precision neuro-optimization” company, combining EEG-guided brain training with supplement formulas matched to individual neurotransmitter profiles. Its flagship Neuromodin Core Stack is paired with a disposable neurotransmitter salivary strip and an app that recalibrates dosage every 30 days, a protocol for which the firm holds two pending patents. Customers are 25-45-year-old knowledge workers, quantified-self enthusiasts, and competitive gamers who track sleep, HRV, and reaction-time metrics and are willing to self-experiment beyond caffeine. They value data-driven tweaking, open-source lab results, and a medical-advisory board that publishes anonymized outcome data every quarter. Neuromodin competes with generic nootropic pills, subscription vitamin packs, and consumer neurostimulation gadgets. It differentiates by integrating real-time neurochemical testing with closed-loop supplementation, offering measurable biomarker shifts rather than relying on subjective “focus” claims.